October 10, 2012 - The court ordered the case closed.
October 5, 2012 - The plaintiffs filed a notice of voluntary dismissal, dismissing all claims against all defendants without prejudice.

June 28, 2012 - Another defendant filed a motion to dismiss.

June 1, 2012 - The defendants filed a motion to dismiss.

May 2, 2012 - The lead plaintiff filed an amended consolidated complaint.

April 2, 2012 - The lead plaintiff and lead counsel were appointed and all cases were consolidated.

February 17, 2012 - Lead plaintiff motions were filed.

December 19, 2011 - An investor in American Depositary Shares (ADS) of China Medical Technologies Inc (NASDAQ: CMED now trading on the OTC sheets as CMEDQ) filed a lawsuit in the U.S. District Court for the Southern District of New York against China Medical Technologies Inc over alleged Violations of Federal Securities Laws.

According to the complaint the plaintiff alleges on behalf of all persons who purchased American Depository Shares ( ADS ) of China Medical Technologies Inc between November 26, 2007 and December 12, 2011, that China Medical Technologies Inc and certain of its directors violated the Securities Exchange Act of 1934 and Rule 10b-5.

On December 6, 2011, Glaucus Research Group issued a report about China Medical Technologies Inc alleging that it has defrauded investors. Glaucus Research Group claims in their report, among other things, that China Medical Technologies Inc paid $28 million for an acquisition from a seller who Glauvus Research Group believes was secretly related to China Medical Technologies Inc’s chairman and that China Medical Technologies Inc sold its primary business segment, responsible for the majority of the firm’s sales since inception, to the chairman at less than 2x trailing EBITDA. Glaucus Research Group said that evidence supports the allegation that China Medical Technologies Inc’s used a complex web of international shell companies and closely related lackeys to embezzle between $20 and $23 million from China Medical Technologies Inc’s investors.

Following the report shares of China Medical Technologies Inc (NASDAQ: CMED) dropped from $3.38 on Monday to $2.55 on Tuesday, December 6.

The next day December 7, China Medical Technologies Inc (NASDAQ: CMED) responded to the allegations raised in a research report by Glaucus Research Group. China Medical Technologies Inc said that the allegations set forth in the Glaucus Research report concern matters which have long been disclosed in China Medical Technologies Inc’s annual reports and press releases, misrepresent the information they present and attribute motives to management that are based on innuendo and fail to take into account business and commercial considerations relevant to the matters discussed in the Report. China Medical Technologies Inc said it denies the allegations entirely.

NASDAQ: CMED shares closed on December 7 at $3.25 per share and fell during December 16, 2011 to as low as $2.36 per share.